ISOPP’s Publication on Biosimilars is published as a supplement in the Journal of Oncology Pharmacy Practice (JOPP).

ISOPP believes that oncology pharmacists have a crucial role to play in the implementation and optimal use of biosimilar medicines in clinical practice. To support oncology pharmacists in fulfilling this role, in 2018 the Secretariat of ISOPP formed a Biosimilars Task Force to review the available evidence, and to discuss the challenges and opportunities presented by the introduction of biosimilars into the oncology and supportive care setting and how these could be addressed.